A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Schizophrenia
Interventions
DRUG

Hydrochloride Carliprazine capsules

Oral administration, once daily, with a total treatment duration of 6 weeks after successful screening.

DRUG

Aripiprazole tablets

Oral administration, once daily, with a total treatment duration of 6 weeks after successful screening.

All Listed Sponsors
lead

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT06589817 - A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophrenia | Biotech Hunter | Biotech Hunter